Constantine Chinoporos, the Chief Operating Officer and Chief Business Officer of Applied Therapeutics, Inc. (NASDAQ:APLT), a clinical-stage biopharmaceutical company with a market capitalization of ...

U.S. stock markets are riding high, with major indexes nearing record levels following a rally led by chipmakers like Nvidia. In this context, penny stocks—typically smaller or newer companies—remain ...

If PH-ILD studies translate into the real world, the market opportunity for Liquidia is enormous. Where should we expect LQDA stock to be in the next few months? Find out.

We recently compiled a list of the 10 Best Rebound Stocks To Invest In Now. In this article, we are going to take a look at ...

Summit Therapeutics Inc. (NASDAQ:SMMT – Free Report) by 13.6% during the 4th quarter, according to the company in its most ...

Kingswood Wealth Advisors LLC bought a new position in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) during ...

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), a commercial-stage biotechnology company with a market capitalization of $428 million specializing in mRNA therapeutics and vaccines, stands at a ...

We recently compiled a list of the 12 Best Booming Stocks to Invest in Now. In this article, we are going to take a look at ...

The recent acquisitions by pharmaceutical giants Johnson & Johnson and Bristol Myers Squibb, worth a combined $28billion, ...

Learn more about whether Biogen Inc. or Neurocrine Biosciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Cynata Therapeutics Limited ( OTCPK:CYYNF) Investor Webinar Conference Call February 5, 2025 6:30 PM ET Lauren Nowak - Media Relations Kilian Kelly - Chief Executive Officer and Managing Director ...